CAPR - capricor.com Qarzning balans kapitallashuviga nisbati

Capricor Therapeutics, Inc. (CAPR) grafik logotipi

Capricor Therapeutics (CAPR) xomashyolarni himoya qiluvchi va yuqori daromadlarni ta'minlovchi murakkab past haroratli biomateriallar transport tizimiga tayanadi. Aksiyalar kotirovkalarining ushbu grafigi 0.36 ko'rsatkichi bilan aktivning dinamikasini tasdiqlaydi. Kompaniya laboratoriya chiqindilarini yo'q qilishning qat'iy standartlariga rioya qilgan holda, ekzosomalar va yurak-qon tomir patologiyalarini hujayraviy davolash atrofida ilmiy ekotizimni yaratmoqda.

CAPR (Capricor Therapeutics, Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha

capricor.com (CAPR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Capricor Therapeutics, Inc.|CAPR - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Capricor Therapeutics, Inc.|CAPR - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Capricor Therapeutics|CAPR - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati capricor.com|CAPR - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Capricor Therapeutics|CAPR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Capricor Therapeutics, Inc.|CAPR - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Capricor Therapeutics, Inc.
Kompaniyaning fundamental tahlili:Capricor - CAPR
Capricor Therapeutics, Inc. asosiy tovari

Biznes sifatini tekshirishda investor umumiy majburiyatlarni kapitalga solishtirish orqali kompaniyaning barqarorligini baholaydi. Ushbu hisoblangan koeffitsiyent balans hisoboti tuzilmasidagi qarz mablag'larining ulushini belgilaydi, bu esa Capricor Therapeutics (CAPR) uchun Duchenne terapiyasini joriy qilishda rahbariyatning moliyaviy intizomini tasdiqlaydi va balans hisobotidagi kapital tuzilmasi xavfining ushbu ko'rsatkichini aks ettiradi.

Capricor Therapeutics (CAPR) raqobatchilari

Balans kapitallashuviga qarzlar JAZZ (Jazz Pharmaceuticals)|cytokinetics.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati PTC Therapeutics (PTCT)|SRRK: Qarzning sof aktivlarga nisbati|CNTA (Centessa Pharmaceuticals PLC) - Qarzning balans kapitallashuviga nisbati|Dyne Corp (DYN) - Qarzning balans qiymatiga nisbati|EWTX (Edgewise Therapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar rapportrx.com (RAPP)|Alumis (ALMS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ZVRA (Zevra Therapeutics Inc)|CTNM - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Larimar Corp LRMR|TRDA (Entrada Therapeutics) - Balans kapitallashuviga qarzlar|channeltherapeutics.com (PTHS) - Balans qiymatiga qarzlar|MNOV: Qarzning balans qiymatiga nisbati|SER (Serina Therapeutics Inc) - Balans kapitallashuviga qarzlar|BTAI - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati PMN|Apimeds Pharmaceuticals - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar AEON (aeonbiopharma.com)|Qarzning balans kapitallashuviga nisbati NLS Pharmaceutics NLSP|Bionomics Ltd. - Qarzning balans kapitallashuviga nisbati|HUGE (FSD Pharma) - Qarzning balans kapitallashuviga nisbati|RETA - Balans qiymatiga qarzlar